Oncology & Cancer

FIGO 2018 staging ups discrimination of stage 1B cervical cancer

(HealthDay)—The Federation of Gynecology and Obstetrics (FIGO) 2018 staging schema improves discriminatory ability for women with stage IB cervical tumors, according to a study published online June 11 in Obstetrics & Gynecology.

Oncology & Cancer

Higher surgical volume may improve outcomes in cervical cancer

(HealthDay)—Surgery at high-volume centers is associated with decreased local recurrence risk and improved survival for women with early-stage cervical cancer, according to a study published in the June issue of Obstetrics ...

Oncology & Cancer

How Rwanda could be the first country to wipe out cervical cancer

Girls began queuing at their local school with their friends, waiting for their names to be called. Many were apprehensive. After all, most of them had not had a vaccination since they were babies. It was 2013 and a new vaccine ...

Oncology & Cancer

Urine test could prevent cervical cancer

Urine testing may be as effective as the smear test at preventing cervical cancer, according to new research by University of Manchester scientists.

page 1 from 23

Cervical cancer

Cervical cancer is malignant cancer of the cervix uteri or cervical area. It may present with vaginal bleeding but symptoms may be absent until the cancer is in its advanced stages. Treatment consists of surgery (including local excision) in early stages and chemotherapy and radiotherapy in advanced stages of the disease.

Pap smear screening can identify potentially precancerous changes. Treatment of high grade changes can prevent the development of cancer. In developed countries, the widespread use of cervical screening programs has reduced the incidence of invasive cervical cancer by 50% or more.[citation needed]

Human papillomavirus (HPV) infection is a necessary factor in the development of nearly all cases of cervical cancer. HPV vaccine effective against the two strains of HPV that cause the most cervical cancer has been licensed in the U.S. and the EU. These two HPV strains together are currently responsible for approximately 70% of all cervical cancers. Since the vaccine only covers some high-risk types, women should seek regular Pap smear screening, even after vaccination.

This text uses material from Wikipedia, licensed under CC BY-SA